Centenial Surgical

₹151.9 0.4 | 0.3%

WEBSITE BSE:531380 NSE : CENTENIAL SU 09 Jul, 10:43

Market Cap ₹55 Cr.

Stock P/E -37.9

P/B 1.9

Current Price ₹151.9

Book Value ₹ 79.4

Face Value 10

52W High ₹169.5

Dividend Yield 0%

52W Low ₹ 82.2

Edit Ratio

Centenial Surgical Research see more...

Overview Inc. Year: 1995Industry: Medical Equipment/Supplies/Accessories

Centenial Surgical Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Centenial Surgical Quarterly Results

#(Fig in Cr.)	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Net Sales	13	13	14	13	12	12	14	14	12	13
Other Income	0	0	0	0	0	0	0	0	0	0
Total Income	13	13	14	13	12	12	14	14	12	13
Total Expenditure	12	12	12	12	11	11	12	13	11	11
Operating Profit	1	1	1	1	1	2	2	2	1	2
Interest	0	1	0	1	1	1	1	1	0	2
Depreciation	0	0	0	0	0	0	1	1	1	1
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	0	0	0	0	0	0	0	0	-1	-1
Provision for Tax	0	0	0	0	0	-0	0	0	0	-0
Profit After Tax	0	0	0	0	0	0	0	0	-1	-1
Adjustments	0	0	0	-0	0	0	-0	0	0	-0
Profit After Adjustments	0	0	0	0	0	0	0	0	-1	-1
Adjusted Earnings Per Share	0.8	0.4	0.8	0.6	0.8	0.5	0.8	0.3	-2.3	-3.2

Centenial Surgical Profit & Loss

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Net Sales	52	51	53	53	56	56	37	44	53	51	54	53
Other Income	0	0	0	0	0	0	0	0	0	0	0	0
Total Income	52	51	53	53	56	56	37	44	53	51	54	53
Total Expenditure	47	47	48	48	51	50	32	40	48	46	47	47
Operating Profit	5	5	5	5	5	6	5	5	5	5	7	7
Interest	2	2	2	2	2	2	2	2	2	3	4	4
Depreciation	1	1	1	1	1	2	2	2	1	1	4	4
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	3	2	3	2	3	2	2	1	1	1	-2	-2
Provision for Tax	1	1	1	1	1	1	1	0	1	0	-0	0
Profit After Tax	2	2	2	2	2	1	1	1	1	1	-1	-2
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	2	2	2	2	2	1	1	1	1	1	-1	-2
Adjusted Earnings Per Share	5.2	4.3	4.7	4.2	5.5	3.6	2.6	1.7	2.4	3.1	-4	-4.4

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	6%	7%	-1%	0%
Operating Profit CAGR	40%	12%	3%	3%
PAT CAGR	-200%	NAN%	NAN%	NAN%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	19%	46%	37%	13%
ROE Average	-5%	1%	2%	5%
ROCE Average	5%	7%	8%	11%

Centenial Surgical Balance Sheet

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Shareholder's Funds	21	23	24	26	28	29	30	30	31	32	31
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	1	1	1	1	1	1	1	0	0	0	0
Other Non-Current Liabilities	2	2	2	2	1	9	8	7	6	14	22
Total Current Liabilities	31	27	28	26	26	31	32	24	29	33	32
Total Liabilities	55	53	56	55	57	69	70	61	66	79	85
Fixed Assets	4	4	4	4	4	10	9	8	6	13	20
Other Non-Current Assets	0	0	0	0	0	1	0	0	1	1	2
Total Current Assets	51	49	52	51	52	58	61	53	59	65	63
Total Assets	55	53	56	55	57	69	70	61	66	79	85

Centenial Surgical Cash Flow

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Opening Cash & Cash Equivalents	1	2	1	1	1	0	1	1	0	0	1
Cash Flow from Operating Activities	0	-2	-0	2	2	2	2	5	1	6	17
Cash Flow from Investing Activities	-0	-0	-2	-1	-1	-1	-1	-0	-0	-8	-12
Cash Flow from Financing Activities	1	1	2	-1	-1	-0	-1	-5	-1	2	-6
Net Cash Inflow / Outflow	1	-1	-0	0	-1	0	-0	-0	0	0	-0
Closing Cash & Cash Equivalent	2	1	1	1	0	1	1	0	0	1	0

Centenial Surgical Ratios

#	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Earnings Per Share (Rs)	5.25	4.28	4.71	4.23	5.53	3.55	2.64	1.72	2.43	3.11	-4.01
CEPS(Rs)	7.53	6.13	6.32	5.87	7.43	7.81	6.89	5.9	5.99	6.91	7.65
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	53.29	57.57	62.28	66.51	72.03	73.55	76.19	77.91	80.33	83.44	79.43
Core EBITDA Margin(%)	9.05	8.69	9.08	8.46	9.44	10.65	13.83	10.09	8.36	10.06	11.99
EBIT Margin(%)	8.28	7.48	8.17	7.44	8.44	8.02	9.88	6.76	6.13	7.6	4.27
Pre Tax Margin(%)	5.27	4.35	4.82	4.58	5.07	3.87	4.14	2.42	2.78	2.49	-3.02
PAT Margin (%)	3.48	2.87	3.25	2.92	3.6	2.33	2.6	1.41	1.68	2.22	-2.73
Cash Profit Margin (%)	4.99	4.11	4.36	4.06	4.84	5.12	6.8	4.85	4.15	4.93	5.22
ROA(%)	3.64	2.89	3.17	2.77	3.6	2.06	1.38	0.95	1.39	1.56	-1.79
ROE(%)	10.37	7.72	7.86	6.56	7.98	4.88	3.52	2.23	3.07	3.8	-4.93
ROCE(%)	14.22	11.74	14.02	14.84	16.75	12.64	8.65	7.27	8.02	8.87	5.09
Receivable days	127.54	128.23	129.93	128.11	126.33	144.58	226.09	172.23	139.05	140.46	126.86
Inventory Days	135.98	153.42	183.5	208.31	196.63	203.52	338.14	281.38	240.91	284.36	293.26
Payable days	249.01	221.97	136.29	138.3	125.05	156.01	406.55	177.73	189.11	234.8	178.88
PER(x)	9.91	15.85	15.64	19.4	8.94	9.8	16.22	35.34	25.4	29.38	0
Price/Book(x)	0.98	1.18	1.18	1.23	0.69	0.47	0.56	0.78	0.77	1.09	1.38
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	0.57	0.71	0.52	0.57	0.34	0.44	0.77	0.7	0.61	0.92	0.97
EV/Core EBITDA(x)	5.44	7.74	5.56	6.64	3.48	4.11	5.49	6.89	7.08	8.92	7.98
Net Sales Growth(%)	1.49	-0.6	2.7	-0.18	6.27	-0.79	-33.59	20.29	18.52	-2.78	4.55
EBIT Growth(%)	12.34	-10.6	6.01	-9.05	20.47	-5.68	-18.21	-17.74	7.59	20.42	-41.27
PAT Growth(%)	6.91	-18.5	10.13	-10.28	30.76	-35.74	-25.78	-34.8	41.27	28.04	-229.03
EPS Growth(%)	6.91	-18.5	10.13	-10.28	30.76	-35.74	-25.78	-34.8	41.27	28.04	-229.03
Debt/Equity(x)	0.58	0.58	0.05	0.05	0.04	0.44	0.46	0.31	0.32	0.45	0.4
Current Ratio(x)	1.65	1.83	1.83	1.94	2	1.87	1.92	2.2	2.04	1.99	1.98
Quick Ratio(x)	0.93	0.94	0.78	0.78	0.86	0.83	0.77	0.87	0.76	0.69	0.61
Interest Cover(x)	2.75	2.39	2.44	2.59	2.5	1.93	1.72	1.56	1.83	1.49	0.59
Total Debt/Mcap(x)	0.65	0.53	0.04	0.04	0.07	1	0.86	0.42	0.44	0.43	0.31

Centenial Surgical Shareholding Pattern

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	44.78	45.48	46.89	46.89	46.89	46.89	46.89	46.89	46.89	46.89
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	55.22	54.52	53.11	53.11	53.11	53.11	53.11	53.11	53.11	53.11
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	0.16	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.2	0.2	0.19	0.19	0.19	0.19	0.19	0.19	0.19	0.19
Others	0	0	0	0	0	0	0	0	0	0
Total	0.36	0.36	0.36	0.36	0.36	0.36	0.36	0.36	0.36	0.36

Pros

Debtor days have improved from 234.8 to 178.88days.
Company is almost debt free.

Cons

Promoter holding is low: 46.89%.
Company has a low return on equity of 1% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.